Search results
Results from the WOW.Com Content Network
Bristol Myers Squibb charges an annual list price of about $7,100 for Eliquis in the U.S., compared to around $900 in Canada and about $650 in France. J&J’s Stelara is $79,000 in the U.S., but ...
Eliquis, Bristol Myers Squibb and Pfizer : $231 per ... The lawsuit by PhRMA is awaiting a change in location after a Texas judge dismissed the case saying his court lacks jurisdiction. No new ...
The U.S. government on Tuesday released a list of 10 prescription medicines that will be subject to the first-ever price negotiations by the Medicare health program that covers Americans aged 65 ...
Apixaban is recommended by the National Institute for Health and Clinical Excellence for the prevention of stroke and systemic embolism in people with non-valvular atrial fibrillation and at least one of the following risk factors: prior stroke or transient ischemic attack, age 75 years or older, diabetes, or symptomatic heart failure.
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
The following is a list of the 20 largest settlements reached between the United States Department of Justice and pharmaceutical companies from 2001 to 2013, ordered by the size of the total settlement.
Franklin and his attorney, Thomas M. Greene, filed a lawsuit, Franklin v. Parke-Davis, under the False Claims Act in federal district court in Boston. In the first off-label promotion case ever litigated in a whistleblower suit under the False Claims Act, the settlement was announced after eight years of litigation in May 2004.
The lawsuits have not slowed the implementation timeline: The government must make its initial offer by Feb. 1 to the companies that make the 10 designated drugs.